Citius raises $36.5m for Lymphir commercialisation

The capital includes a $25m term loan and a warrant exercise agreement expected to yield $11.5m.

By Salong Debbarma· Pharmaceutical Technology· 5 months ago· 2 min read

The capital includes a $25m term loan and a warrant exercise agreement expected to yield $11.5m. For the full story, visit the source.

This summary is sourced from Pharmaceutical Technology. Read the full article at:Pharmaceutical Technology